InGeneron, Inc. Announces EU Quality Management System Certificate Under MDR Regulation (EU) 2017/745 for Medical Devices
InGeneron Publishes Landmark Study Demonstrating Structural Tendon Regeneration with Autologous Cell Therapy System
InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff Tears
New Study Reports Broad Applicability of InGeneron’s Regenerative Cell Therapy System Across Patient Groups
In the US InGeneron’s Transpose® RT cell therapy platform is for investigational use only. By Clicking ‘Continue’ I confirm acknowledgment
